Fujian Cosunter Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Fujian Guangshengtang Pharmaceutical Co., Ltd., founded in June 2001, is a national key high-tech enterprise focusing on the fields of liver disease, antiviral and anti infective drugs. It is also an enterprise with five major anti hepatitis B clinical drugs. The company adheres to the development strategy of transforming from a traditional generic pharmaceutical enterprise to an innovative pharmaceutical enterprise, and continues to introduce and develop a class of innovative drugs and high-end generic drugs. The company has several sub business units and more than ten best-selling varieties, covering fields such as liver disease, andrology, cardiovascular, traditional Chinese patent medicines and simple preparations, etc; The company has been rated as the National Enterprise Technology Center and a demonstration enterprise of China's intellectual property advantages. The company was successfully listed on the Shenzhen Stock Exchange on April 22, 2015 (stock code 300436). |
| Headquarter | Ningde |
| Establish Date | 6/28/2001 |
| Listed Code | 300436.SZ |
| Listed Date | 4/22/2015 |
| Chairman | Li Guoping. |
| CEO | Li Guoping. |
| Website | www.cosunter.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
